NPCE
Neuropace Inc
14.00$
-1.7%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -23.4% | +67.2% | -15.8% | +4.3% | +12.6% | -18.1% | +6.4% | +3.4% | -10.3% | +9.4% | +14.6% | +13.2% | +14.1% | -0.5% | +9.6% | +0.6% | +6.2% | +9.4% | +1.9% | +4.9% | +4.4% | +16.3% | -2.8% | -17.0% | +3.4% | – | |
| – | -24.0% | +44.0% | -20.7% | +7.5% | +20.1% | -13.4% | +3.1% | +6.6% | -12.2% | +16.8% | +24.9% | +2.9% | +10.7% | -7.6% | +6.5% | +7.0% | +7.1% | +10.1% | -6.4% | -1.8% | +4.0% | +14.8% | -2.8% | -33.1% | -2.5% | – | |
| – | -23.2% | +76.6% | -14.2% | +3.3% | +10.2% | -19.8% | +7.6% | +2.3% | -9.6% | +6.7% | +10.5% | +17.8% | +15.4% | +2.2% | +10.7% | -1.5% | +5.9% | +9.1% | +5.0% | +7.1% | +4.6% | +16.7% | -2.8% | -12.3% | +4.8% | – | |
| – | -32.7% | +13.5% | +6.2% | +4.6% | +8.2% | -2.4% | +23.5% | +4.3% | +1.6% | -1.0% | -9.3% | +3.4% | +1.5% | -10.3% | +12.1% | +7.6% | +4.9% | -5.1% | +5.1% | +23.0% | -8.0% | -3.9% | +6.9% | +2.3% | -4.0% | – | |
| – | -26.9% | +25.6% | +3.3% | +13.5% | +15.2% | -1.1% | +24.7% | +5.9% | +2.6% | -1.7% | +8.1% | -1.1% | +7.9% | -7.6% | -1.3% | +14.3% | -69.9% | +206.2% | -0.8% | -70.7% | +50.0% | -24.3% | -4.6% | +10.5% | +3.8% | – | |
| – | -29.1% | +21.1% | +4.3% | +10.4% | +12.9% | -1.5% | +24.3% | +5.4% | +2.3% | -1.5% | +2.7% | +0.2% | +6.1% | -8.3% | +2.3% | +12.3% | -2.5% | -3.4% | +0.9% | +13.3% | +11.0% | -4.8% | -6.0% | +5.7% | +1.8% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +27.2% | -26.8% | -34.0% | +0.4% | +1.3% | -2.5% | +2.0% | -1.7% | +1.2% | +2.9% | +1.8% | +1.2% | +8.1% | +3.1% | +2.1% | +1.0% | -4.1% | +0.7% | +0.5% | -1.8% | -4.4% | -20.1% | -2.7% | -4.9% | +1.2% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -51.6% | +15.1% | -20.4% | -159.3% | – | – | -110.2% | – | +1.0% | -7.6% | -18.9% | +212.4% | -44.1% | +2.6% | -471.8% | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.